So, inhibition of the NF-κB pathway using 1 μM EF decreased the cancer cells proliferation less than 60 % in pancreatic cancer cells (MiaPaCa-2 and PANC-1) (Lagisetty et al., 2012[16]). The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.